FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Improving cancer care by partnering not-for-profits based in the UK and Ireland with colleagues in LMICs

An overview of LGCW 2025

Innovating cancer care access for low and middle-income countries

How cancer misinformation can impact historically marginalised communities

Rebuilding trust in healthcare in historically marginalised communities

Empowering Caribbean and African communities to take charge of cancer prevention

Evolving conversations on value and equity in cancer care

What are the barriers for diverse and inclusive clinical trial recruitment?

Improving diversity in the participation of clinical trials in the UK

Reducing disparities through primary care: improving early detection and screening

Using lived experience of pancreatic cancer to build faith-based support